Regulated Information

21 results have been found

Advanced search
Categories
Years
Number of results
1 2 3 | »
Outstanding shares and voting rights statements | Press releases

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Press releases

DBV Technologies CEO, Chairman, and Co-Founder, Dr. Pierre-Henri Benhamou Recognized for His Lasting Impact on the Food Allergy Community and Research Advancement by FARE (Food Allergy Research & Education)

Press releases

DBV Technologies to Attend Citi’s 2017 Global Healthcare Conference

Press releases

DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients

Press releases

DBV Technologies Announces Publication of Positive Data from Phase IIb Trial and Long-Term Study of Viaskin Peanut inthe Journal of the American Medical Association

Outstanding shares and voting rights statements | Press releases

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Press releases

DBV Technologies Reports September 30, 2017 Cash Position

Press releases

DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age

Outstanding shares and voting rights statements | Press releases

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Press releases

DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut

1 2 3 | »